- Nuclear Medicine Imaging in Differentiated Thyroid Cancer: Summary of the Korean Thyroid Association Guidelines 2024 from Nuclear Medicine Perspective, Part‑I
-
Oh S, Park S, Chong A, Kim K, Bang J, Seo Y, Hong C, Lee S
- KMID: 2565518
- Nucl Med Mol Imaging.
- 2025 Feb;59(1):1-7.
- doi: 10.1007/s13139-024-00885-y
Thyroid cancer, one of the most common endocrine tumors, generally has a favorable prognosis but remains a significant medical and societal concern due to its high incidence. Early diagnosis and... -
- CITED
-
- Close
- SHARE
-
- Close
- 18F-FDOPA PET/CT in Oncology: Procedural Guideline by the Korean Society of Nuclear Medicine
-
Park YJ, Choi JH, Lee H, Moon SH, Lee I, Lee J, Yoo J, Choi JY, The Korean Society of Nuclear Medicine Medical Affairs Committee
- KMID: 2565521
- Nucl Med Mol Imaging.
- 2025 Feb;59(1):41-49.
- doi: 10.1007/s13139-024-00899-6
This guideline outlines the use of 3,4-dihydroxy-6- 18F-fluoro-L-phenylalanine positron emission tomography / computed tomography for the diagnosis and management of neuroendocrine tumors, brain tumors, and other tumorous conditions. It provides... -
- CITED
-
- Close
- SHARE
-
- Close
- Radioactive Iodine Therapy in Differentiated Thyroid Cancer: Summary of the Korean Thyroid Association Guidelines 2024 from Nuclear Medicine Perspective, Part-II
-
Oh S, Park S, Chong A, Kim K, Bang J, Seo Y, Hong C, Lee S
- KMID: 2565519
- Nucl Med Mol Imaging.
- 2025 Feb;59(1):8-26.
- doi: 10.1007/s13139-024-00886-x
Thyroid cancer, one of the most common endocrine tumors, generally has a favorable prognosis but remains a significant medical and societal concern due to its high incidence. Early diagnosis and... -
- CITED
-
- Close
- SHARE
-
- Close
- 18F‑FDG PET/CT in Inflammation and Infection: Procedural Guideline by the Korean Society of Nuclear Medicine
-
Choi J, Park Y, Lee H, Kwon H, Oh J, Lim C, Han E, Choi J, The Korean Society of Nuclear Medicine Medical Affairs Committee
- KMID: 2565520
- Nucl Med Mol Imaging.
- 2025 Feb;59(1):27-40.
- doi: 10.1007/s13139-024-00894-x
This guideline outlines the use of 18F-fluoro-2-deoxyglucose positron emission tomography / computed tomography for the diagnosis and management of infectious and inflammatory diseases. It provides detailed recommendations for healthcare providers... -
- CITED
-
- Close
- SHARE
-
- Close
- Correction to: Imaging Procedure and Clinical Studies of [18F]FP‑CIT PET
-
Sung C, Oh SJ, Kim JS
- KMID: 2565528
- Nucl Med Mol Imaging.
- 2025 Feb;59(1):93-93.
- doi: 10.1007/s13139-024-00881-2
-
- CITED
-
- Close
- SHARE
-
- Close
- Correction to: Recent Update on PET/CT Radiotracers for Imaging Cerebral Glioma
-
Kim D, Lee S, Hwang HS, Kim SJ, Yun M
- KMID: 2565526
- Nucl Med Mol Imaging.
- 2025 Feb;59(1):91-91.
- doi: 10.1007/s13139-024-00879-w
-
- CITED
-
- Close
- SHARE
-
- Close
- Diagnostic Ability and Correlation of Digital 11C-Methionine PET/CT in Primary Hyperparathyroidism with Inconclusive Standard Imaging
-
Jeong HB, Kim Yi, Yoon S, Lee DY, Kim BJ, Lee SH, Ryu JS
- KMID: 2565524
- Nucl Med Mol Imaging.
- 2025 Feb;59(1):72-78.
- doi: 10.1007/s13139-024-00878-x
Purpose 11C-Methionine PET/CT is a promising method for detecting parathyroid lesions in patients with primary hyperparathyroidism (PHPT). We aimed to determine the diagnostic ability and correlation of digital 11C-Methionine PET/CT... -
- CITED
-
- Close
- SHARE
-
- Close
- Harnessing Terbium Radioisotopes for Clinical Advancements: A Systematic Review
-
Abdlkadir A, Rosar F, Jalilian A, Moghrabi S, Al‑Balooshi B, Rabei O, Kairemo K, Al‑Ibraheem A
- KMID: 2565522
- Nucl Med Mol Imaging.
- 2025 Feb;59(1):50-61.
- doi: 10.1007/s13139-024-00891-0
Background this systematic review was conducted to assess the practical application of terbium radioisotopes, utilizing systematic search methodologies to identify relevant studies. Methods the databases of PubMed, Web of Science,... -
- CITED
-
- Close
- SHARE
-
- Close
- Preparation and Biodistribution Assessment of 177Lu-curcumin as a Possible Therapeutic Agent
-
Vosoughi S, Salek N, maragheh Mg, Arani SS, Samani AB, Arabieh M
- KMID: 2565523
- Nucl Med Mol Imaging.
- 2025 Feb;59(1):62-71.
- doi: 10.1007/s13139-024-00875-0
Purpose Curcumin as a potent anti-inflammatory and cancer-prevention molecule was labeled with n.c.a 177Lu. The combi- nation of 177Lu as a theranostic agent and curcumin as an anti-cancer can be considered... -
- CITED
-
- Close
- SHARE
-
- Close
- Exploring the Correlation Between Multiparameters Detected in Primary Prostate Cancer using F‑18 PSMA‑1007 PET/MRI and their Potential for Predicting Metastasis
-
Cheewadhanaraks S, Sereeborwornthanasak K, Siripongsatian D, Jantarato A, Promteangtrong C, Kunawudhi A, Kiatkittikul P, Boonkawin N, Boonsingma N, Chotipanich C
- KMID: 2565525
- Nucl Med Mol Imaging.
- 2025 Feb;59(1):79-90.
- doi: 10.1007/s13139-024-00884-z
Purpose Prostate-specific membrane antigen (PSMA) Positron emission tomography/magnetic resonance imaging (PET/ MRI) surpasses conventional MRI (cMRI) in prostate cancer (PCa) evaluation. Our objective is to evaluate correlation of quantitative parameters... -
- CITED
-
- Close
- SHARE
-
- Close
- Correction to: Dual Radionuclide Therapy: The Synergistic Effects of [ 161Tb]Tb-PSMA and [ 177 Lu]Lu-PSMA in Advanced Prostate Cancer Post [ 177 Lu]Lu-PSMA Failure
-
Abdlkadir AS, Abufara A, Al-Ibraheem A
- KMID: 2565529
- Nucl Med Mol Imaging.
- 2025 Feb;59(1):94-94.
- doi: 10.1007/s13139-024-00887-w
-
- CITED
-
- Close
- SHARE
-
- Close
- Correction to: The Development Status of PET Radiotracers for Evaluating Neuroinflammation
-
Lee N, Choi JY, Ryu YH
- KMID: 2565527
- Nucl Med Mol Imaging.
- 2025 Feb;59(1):92-92.
- doi: 10.1007/s13139-024-00880-3
-
- CITED
-
- Close
- SHARE
-
- Close
